{
  "id": 41905,
  "title": "What will be the reported Q1 2026 global revenue for Zepbound (tirzepatide)?",
  "short_title": "What will be the reported Q1 2026 global revenue for Zepbound (tirzepatide)?",
  "url_title": "What will be the reported Q1 2026 global revenue for Zepbound (tirzepatide)?",
  "slug": "what-will-be-the-reported-q1-2026-global-revenue-for-zepbound-tirzepatide",
  "author_id": 276265,
  "author_username": "AutoQuestionsBot",
  "coauthors": [],
  "created_at": "2026-01-28T08:26:56.229780Z",
  "published_at": "2026-02-01T19:30:00Z",
  "edited_at": "2026-02-01T19:42:01.611314Z",
  "curation_status": "approved",
  "curation_status_updated_at": "2026-01-28T08:27:05.012751Z",
  "comment_count": 0,
  "status": "open",
  "resolved": false,
  "actual_close_time": null,
  "scheduled_close_time": "2026-02-01T21:00:00Z",
  "scheduled_resolve_time": "2026-05-01T00:00:00Z",
  "actual_resolve_time": null,
  "open_time": "2026-02-01T19:30:00Z",
  "nr_forecasters": 41,
  "html_metadata_json": null,
  "projects": {
    "category": [
      {
        "id": 3698,
        "name": "Economy & Business",
        "slug": "economy-business",
        "emoji": "\ud83d\udcbc",
        "description": "Economy & Business",
        "type": "category"
      },
      {
        "id": 3691,
        "name": "Health & Pandemics",
        "slug": "health-pandemics",
        "emoji": "\ud83e\udda0",
        "description": "Health & Pandemics",
        "type": "category"
      }
    ],
    "tournament": [
      {
        "id": 32916,
        "type": "tournament",
        "name": "Spring 2026 AI Forecasting Benchmark Tournament",
        "slug": "spring-aib-2026",
        "header_image": "https://cdn.metaculus.com/aib-spring-cover.webp",
        "prize_pool": "50000.00",
        "start_date": "2026-01-05T00:00:00Z",
        "close_date": "2026-07-05T00:00:00Z",
        "forecasting_end_date": "2026-05-06T00:00:00Z",
        "html_metadata_json": null,
        "is_ongoing": true,
        "user_permission": null,
        "order": 0,
        "created_at": "2025-12-12T16:53:45.337955Z",
        "edited_at": "2026-02-01T19:42:01.732450Z",
        "score_type": "spot_peer_tournament",
        "default_permission": "forecaster",
        "visibility": "not_in_main_feed",
        "show_on_homepage": true,
        "is_current_content_translated": false,
        "bot_leaderboard_status": "bots_only",
        "description_preview": "<p>Welcome to the Spring 2026 AI Forecasting Benchmark! This is a bot-only competition where bot-makers attempt to push AI to its limits in"
      }
    ],
    "default_project": {
      "id": 32916,
      "type": "tournament",
      "name": "Spring 2026 AI Forecasting Benchmark Tournament",
      "slug": "spring-aib-2026",
      "header_image": "https://cdn.metaculus.com/aib-spring-cover.webp",
      "prize_pool": "50000.00",
      "start_date": "2026-01-05T00:00:00Z",
      "close_date": "2026-07-05T00:00:00Z",
      "forecasting_end_date": "2026-05-06T00:00:00Z",
      "html_metadata_json": null,
      "is_ongoing": true,
      "user_permission": null,
      "order": 0,
      "created_at": "2025-12-12T16:53:45.337955Z",
      "edited_at": "2026-02-01T19:42:01.732450Z",
      "score_type": "spot_peer_tournament",
      "default_permission": "forecaster",
      "visibility": "not_in_main_feed",
      "show_on_homepage": true,
      "is_current_content_translated": false,
      "bot_leaderboard_status": "bots_only",
      "description_preview": "<p>Welcome to the Spring 2026 AI Forecasting Benchmark! This is a bot-only competition where bot-makers attempt to push AI to its limits in"
    }
  },
  "question": {
    "id": 41643,
    "title": "What will be the reported Q1 2026 global revenue for Zepbound (tirzepatide)?",
    "created_at": "2026-01-28T08:26:56.230181Z",
    "open_time": "2026-02-01T19:30:00Z",
    "cp_reveal_time": "2026-02-01T21:00:00Z",
    "spot_scoring_time": "2026-02-01T21:00:00Z",
    "scheduled_resolve_time": "2026-05-01T00:00:00Z",
    "actual_resolve_time": null,
    "resolution_set_time": null,
    "scheduled_close_time": "2026-02-01T21:00:00Z",
    "actual_close_time": "2026-02-01T21:00:00Z",
    "type": "numeric",
    "options": null,
    "all_options_ever": null,
    "options_history": null,
    "group_variable": "",
    "status": "open",
    "possibilities": null,
    "resolution": null,
    "include_bots_in_aggregates": true,
    "question_weight": 1.0,
    "default_score_type": "spot_peer",
    "default_aggregation_method": "unweighted",
    "label": "",
    "unit": "$",
    "open_upper_bound": true,
    "open_lower_bound": false,
    "inbound_outcome_count": 200,
    "scaling": {
      "range_min": 0.0,
      "range_max": 10000000000.0,
      "nominal_min": 0.0,
      "nominal_max": 10000000000.0,
      "zero_point": null,
      "open_upper_bound": true,
      "open_lower_bound": false,
      "inbound_outcome_count": 200,
      "continuous_range": [
        0.0,
        50000000.0,
        100000000.0,
        150000000.0,
        200000000.0,
        250000000.0,
        300000000.0,
        350000000.00000006,
        400000000.0,
        450000000.0,
        500000000.0,
        550000000.0,
        600000000.0,
        650000000.0,
        700000000.0000001,
        750000000.0,
        800000000.0,
        850000000.0000001,
        900000000.0,
        950000000.0,
        1000000000.0,
        1050000000.0,
        1100000000.0,
        1150000000.0,
        1200000000.0,
        1250000000.0,
        1300000000.0,
        1350000000.0,
        1400000000.0000002,
        1450000000.0,
        1500000000.0,
        1550000000.0,
        1600000000.0,
        1650000000.0,
        1700000000.0000002,
        1750000000.0000002,
        1800000000.0,
        1850000000.0,
        1900000000.0,
        1950000000.0,
        2000000000.0,
        2050000000.0000002,
        2100000000.0,
        2150000000.0,
        2200000000.0,
        2250000000.0,
        2300000000.0,
        2350000000.0,
        2400000000.0,
        2450000000.0,
        2500000000.0,
        2550000000.0,
        2600000000.0,
        2650000000.0,
        2700000000.0,
        2750000000.0,
        2800000000.0000005,
        2850000000.0000005,
        2900000000.0,
        2950000000.0,
        3000000000.0,
        3050000000.0,
        3100000000.0,
        3150000000.0,
        3200000000.0,
        3250000000.0,
        3300000000.0,
        3350000000.0,
        3400000000.0000005,
        3450000000.0000005,
        3500000000.0000005,
        3550000000.0,
        3600000000.0,
        3650000000.0,
        3700000000.0,
        3750000000.0,
        3800000000.0,
        3850000000.0,
        3900000000.0,
        3950000000.0,
        4000000000.0,
        4050000000.0000005,
        4100000000.0000005,
        4150000000.0000005,
        4200000000.0,
        4250000000.0,
        4300000000.0,
        4350000000.0,
        4400000000.0,
        4450000000.0,
        4500000000.0,
        4550000000.0,
        4600000000.0,
        4650000000.0,
        4700000000.0,
        4750000000.0,
        4800000000.0,
        4850000000.0,
        4900000000.0,
        4950000000.0,
        5000000000.0,
        5050000000.0,
        5100000000.0,
        5150000000.0,
        5200000000.0,
        5250000000.0,
        5300000000.0,
        5350000000.0,
        5400000000.0,
        5450000000.0,
        5500000000.0,
        5550000000.000001,
        5600000000.000001,
        5650000000.000001,
        5700000000.000001,
        5750000000.000001,
        5800000000.0,
        5850000000.0,
        5900000000.0,
        5950000000.0,
        6000000000.0,
        6050000000.0,
        6100000000.0,
        6150000000.0,
        6200000000.0,
        6250000000.0,
        6300000000.0,
        6350000000.0,
        6400000000.0,
        6450000000.0,
        6500000000.0,
        6550000000.0,
        6600000000.0,
        6650000000.0,
        6700000000.0,
        6750000000.0,
        6800000000.000001,
        6850000000.000001,
        6900000000.000001,
        6950000000.000001,
        7000000000.000001,
        7050000000.0,
        7100000000.0,
        7150000000.0,
        7200000000.0,
        7250000000.0,
        7300000000.0,
        7350000000.0,
        7400000000.0,
        7450000000.0,
        7500000000.0,
        7550000000.0,
        7600000000.0,
        7650000000.0,
        7700000000.0,
        7750000000.0,
        7800000000.0,
        7850000000.0,
        7900000000.0,
        7950000000.0,
        8000000000.0,
        8050000000.000001,
        8100000000.000001,
        8150000000.000001,
        8200000000.000001,
        8250000000.000001,
        8300000000.000001,
        8350000000.0,
        8400000000.0,
        8450000000.0,
        8500000000.0,
        8550000000.0,
        8600000000.0,
        8650000000.0,
        8700000000.0,
        8750000000.0,
        8800000000.0,
        8850000000.0,
        8900000000.0,
        8950000000.0,
        9000000000.0,
        9050000000.0,
        9100000000.0,
        9150000000.0,
        9200000000.0,
        9250000000.0,
        9300000000.0,
        9350000000.0,
        9400000000.0,
        9450000000.0,
        9500000000.0,
        9550000000.0,
        9600000000.0,
        9650000000.0,
        9700000000.0,
        9750000000.0,
        9800000000.0,
        9850000000.0,
        9900000000.0,
        9950000000.0,
        10000000000.0
      ]
    },
    "group_rank": null,
    "coherence_links": null,
    "coherence_link_aggregations": null,
    "description": "Zepbound is a key driver of Eli Lilly's growth in the obesity market, and its performance is a major indicator of the company's ability to scale production and meet high consumer demand.\n\n`{\"format\":\"bot_tournament_question\",\"info\":{\"hash_id\":\"df4391367ffc6462\",\"sheet_id\":67}}`",
    "resolution_criteria": "This question resolves to the value of the 'Global' or 'Total' net sales (revenue) for Zepbound (tirzepatide) for the first quarter (Q1) of 2026, as reported in Eli Lilly and Company's quarterly earnings materials. Resolution will be based on the first official earnings release or SEC filing (10-Q) issued by Eli Lilly and Company for the quarter ending March 31, 2026. Source: https://investor.lilly.com/financial-information/quarterly-results",
    "fine_print": "Subsequent restatements of the figure in later quarters will not be considered for resolution.",
    "short_title": "What will be the reported Q1 2026 global revenue for Zepbound (tirzepatide)?",
    "post_id": 41905,
    "aggregations": {
      "unweighted": {
        "history": [],
        "latest": null,
        "score_data": {},
        "movement": null
      }
    },
    "average_coverage": null
  },
  "user_permission": "forecaster",
  "vote": {
    "score": 0,
    "user_vote": null
  },
  "forecasts_count": 41,
  "key_factors": [],
  "is_current_content_translated": false
}